Essex, United Kingdom

David G Evans

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: C4x Discovery Limited. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David G Evans. Retrieved from https://idiyas.com/inventor/david-g-evans-5grw9z86

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David G Evans - Innovator in Therapeutic Compounds

Introduction

David G Evans is a notable inventor based in Essex, GB, recognized for his contributions to the field of medicinal chemistry. With a keen focus on therapeutic compounds, his work primarily revolves around Nrf2 activators, which hold promise for significant advancements in treating diseases linked to oxidative stress.

Latest Patents

Evans holds a patent for "Therapeutic Compounds," which details compounds that act as Nrf2 activators. The invention encompasses processes for the preparation of these compounds, pharmaceutical compositions that incorporate them, and their applications in treating various diseases or disorders associated with Nrf2 activation.

Career Highlights

Currently, David G Evans is associated with C4X Discovery Limited, where he contributes to innovative research and development in the pharmaceutical sector. His expertise and inventions have made a substantial impact on therapeutic strategies and drug discovery.

Collaborations

Throughout his career, Evans has collaborated with esteemed professionals, including Emma Louise Blaney and Duncan J Crick. These partnerships have fostered an environment for creativity and innovation, leading to significant advancements in their collective research efforts.

Conclusion

David G Evans stands out as a prominent figure in the realm of therapeutic innovation, particularly in the area of Nrf2 activators. His patent and collaborative work reflect a dedication to improving healthcare through scientific discoveries and advancements in medicinal compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…